Irish medicine supplies remain strong despite COVID-19
Medicines for Ireland (MFI), the Irish pharmaceutical trade association and the supplier of the majority of medicine in Ireland to the HSE and patients directly
March 16, 2020
News
Medicines for Ireland welcomes EU coordinated approach on medicine supply as Covid-19 cases rise
Medicines for Ireland (MFI), the Irish pharmaceutical trade association, has welcomed the coordinated approach agreed by European Union leaders for the procurement of medicines, medical
March 11, 2020
Irish patients missing out on affordable medicines as outdated purchasing systems resulting in State overpaying for many medicines
The Government continues to overspend millions on expensive big brand medicines despite the availability of more affordable, equally effective generic and biosimilar alternatives. State losing
May 8, 2019
Promised reforms abandoned as State misses out on opportunity to save almost €140 million annually on medicine costs
[vc_row][vc_column][vc_icon icon=”fa fa-file-pdf-o” icon_color=”color-188384″ size=”fa-5x” title=”Generics@5 Report” link=”url:http%3A%2F%2Fwww.medicinesforireland.ie%2Fwp-content%2Fuploads%2F2017%2F06%2FMedicines_for_Ireland-Generics%405.pdf||target:%20_blank|” link_text=”View report”]July 2018[/vc_icon][vc_column_text]A representative body for Ireland’s largest medicine suppliers has warned that medicine costs for the
July 12, 2018
Urgent reforms needed to prevent increased medicine shortages post-Brexit, according to leading pharma body
As healthcare stakeholders gather together today (Monday) as part of a Health Products Regulatory Authority (HPRA) initiative to develop solutions to the growing problem of
July 2, 2018
Ireland well positioned to secure thousands of additional jobs in pharma sector, if EU moves to reform pharma manufacturing regulations
A leading Irish pharma body, Medicines for Ireland, which represents the generics industry here, with members such as Mylan, Teva, Pinewood, Clonmel Healthcare, met with
June 28, 2018
Up to 25,000 pharma jobs if EU alters patent rules
Article by Charlie Taylor Irish Times, Monday 21 May 2018 Biosimilars are medicines that have no clinically meaningful difference from the original patented biologic medication
May 25, 2018
Mylan Country Manager appointed new chairperson of Medicines for Ireland
Medicines for Ireland has announced the appointment of Mylan Ireland Country Manager, Owen McKeon, as new chairperson of the organisation, taking over from Sandra Gannon
May 22, 2018
Government spent €57.5m on three name brand drugs despite cheaper, equally effective alternatives available
THE Government spent €57.5million on three name brand drugs despite cheaper, equally effective alternatives available. The HSE has forked out the cash this year on
November 23, 2017
Medicines for Ireland claim that Irish patients are missing out unfairly
Medicines for Ireland, the representative association for generic and biosimilar suppliers in Ireland, has cautioned that a promised new National Biosimilar Policy may lead to
November 23, 2017
